Mutations downstream of Raf in the Ras/Raf/MEK/ERK cascade have not been frequently detected in human cancer although there are some rare germline mutations detected at MEK1 and MEK2 in cardiofaciocutaneous syndrome (CFC) [82]. This evidence concerns the gene MAP2K1 and cardiofaciocutaneous syndrome.